These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8763839)
1. Immortalisation of a human diploid fibroblast cell strain: a DT-diaphorase paradox. Kuehl BL; Brezden CB; Traver RD; Siegel D; Ross D; Renzing J; Rauth AM Br J Cancer Suppl; 1996 Jul; 27():S19-22. PubMed ID: 8763839 [TBL] [Abstract][Full Text] [Related]
2. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines. Lambert PA; Kang Y; Greaves B; Perry RR J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310 [TBL] [Abstract][Full Text] [Related]
3. Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors. Gan Y; Mo Y; Kalns JE; Lu J; Danenberg K; Danenberg P; Wientjes MG; Au JL Clin Cancer Res; 2001 May; 7(5):1313-9. PubMed ID: 11350900 [TBL] [Abstract][Full Text] [Related]
4. [DT-diaphorase]. Mikami K; Shirakusa T; Tsuruo T Gan To Kagaku Ryoho; 1997 Sep; 24(11):1606-10. PubMed ID: 9309161 [TBL] [Abstract][Full Text] [Related]
5. Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase. Wang X; Doherty GP; Leith MK; Curphey TJ; Begleiter A Br J Cancer; 1999 Jun; 80(8):1223-30. PubMed ID: 10376975 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C. Kuehl BL; Buchwald M; Rauth AM Oncol Res; 1993; 5(6-7):213-21. PubMed ID: 8123941 [TBL] [Abstract][Full Text] [Related]
7. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
8. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671 [TBL] [Abstract][Full Text] [Related]
9. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions. Begleiter A; Leith MK Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273 [TBL] [Abstract][Full Text] [Related]
10. Reversal of mitomycin C resistance by overexpression of bioreductive enzymes in Chinese hamster ovary cells. Baumann RP; Hodnick WF; Seow HA; Belcourt MF; Rockwell S; Sherman DH; Sartorelli AC Cancer Res; 2001 Nov; 61(21):7770-6. PubMed ID: 11691791 [TBL] [Abstract][Full Text] [Related]
11. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines. Mikami K; Naito M; Tomida A; Yamada M; Sirakusa T; Tsuruo T Cancer Res; 1996 Jun; 56(12):2823-6. PubMed ID: 8665520 [TBL] [Abstract][Full Text] [Related]
12. [Mechanism of resistance to mitomycin C in a human bladder cancer cell line]. Xu B; Sun Y; Singh SV Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):343-6. PubMed ID: 8697971 [TBL] [Abstract][Full Text] [Related]
13. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia. Begleiter A; Robotham E; Leith MK Mol Pharmacol; 1992 Apr; 41(4):677-82. PubMed ID: 1373799 [TBL] [Abstract][Full Text] [Related]
14. Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumors. Li D; Gan Y; Wientjes MG; Badalament RA; Au JL J Urol; 2001 Dec; 166(6):2500-5. PubMed ID: 11696818 [TBL] [Abstract][Full Text] [Related]
15. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy. Begleiter A; Leith MK; Curphey TJ; Doherty GP Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243 [TBL] [Abstract][Full Text] [Related]
16. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development. Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802 [TBL] [Abstract][Full Text] [Related]
17. Involvement of activator protein-1 and nuclear factor-kappaB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment. Yao KS; Hageboutros A; Ford P; O'Dwyer PJ Mol Pharmacol; 1997 Mar; 51(3):422-30. PubMed ID: 9058597 [TBL] [Abstract][Full Text] [Related]
18. [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity]. Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T Gan To Kagaku Ryoho; 1993 Jun; 20(8):1037-41. PubMed ID: 7685584 [TBL] [Abstract][Full Text] [Related]
19. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance. Yoshida T; Tsuda H Biochem Biophys Res Commun; 1995 Sep; 214(2):701-8. PubMed ID: 7677784 [TBL] [Abstract][Full Text] [Related]
20. Over-expression of DT-diaphorase in transfected NIH 3T3 cells does not lead to increased anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs. Powis G; Gasdaska PY; Gallegos A; Sherrill K; Goodman D Anticancer Res; 1995; 15(4):1141-5. PubMed ID: 7653992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]